85 related articles for article (PubMed ID: 25033801)
1. State 1(T) inhibitors of activated Ras.
Kalbitzer HR; Spoerner M
Enzymes; 2013; 33 Pt A():69-94. PubMed ID: 25033801
[TBL] [Abstract][Full Text] [Related]
2. Metal-bis(2-picolyl)amine complexes as state 1(T) inhibitors of activated Ras protein.
Rosnizeck IC; Spoerner M; Harsch T; Kreitner S; Filchtinski D; Herrmann C; Engel D; König B; Kalbitzer HR
Angew Chem Int Ed Engl; 2012 Oct; 51(42):10647-51. PubMed ID: 22996816
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the mode of action of a typical Ras state 1(T) inhibitor.
Rosnizeck IC; Filchtinski D; Lopes RP; Kieninger B; Herrmann C; Kalbitzer HR; Spoerner M
Biochemistry; 2014 Jun; 53(24):3867-78. PubMed ID: 24866928
[TBL] [Abstract][Full Text] [Related]
4. Slow conformational dynamics of the guanine nucleotide-binding protein Ras complexed with the GTP analogue GTPgammaS.
Spoerner M; Nuehs A; Herrmann C; Steiner G; Kalbitzer HR
FEBS J; 2007 Mar; 274(6):1419-33. PubMed ID: 17302736
[TBL] [Abstract][Full Text] [Related]
5. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
Kogut MH; Genovese KJ; He H
Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
[TBL] [Abstract][Full Text] [Related]
6. High-frequency 94 GHz ENDOR characterization of the metal binding site in wild-type Ras x GDP and its oncogenic mutant G12V in frozen solution.
Bennati M; Hertel MM; Fritscher J; Prisner TF; Weiden N; Hofweber R; Spörner M; Horn G; Kalbitzer HR
Biochemistry; 2006 Jan; 45(1):42-50. PubMed ID: 16388579
[TBL] [Abstract][Full Text] [Related]
7. What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf.
Filchtinski D; Sharabi O; Rüppel A; Vetter IR; Herrmann C; Shifman JM
J Mol Biol; 2010 Jun; 399(3):422-35. PubMed ID: 20361980
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism for the modulation of the Ras-effector interaction by small molecules.
Spoerner M; Graf T; König B; Kalbitzer HR
Biochem Biophys Res Commun; 2005 Aug; 334(2):709-13. PubMed ID: 16036132
[TBL] [Abstract][Full Text] [Related]
9. Discovery of small-molecule Ras inhibitors that display antitumor activity by interfering with Ras·GTP-effector interaction.
Shima F; Yoshikawa Y; Matsumoto S; Kataoka T
Enzymes; 2013; 34 Pt. B():1-23. PubMed ID: 25034098
[TBL] [Abstract][Full Text] [Related]
10. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
11. High Pressure Promotes Binding of the Allosteric Inhibitor Zn
Girard E; Lopes P; Spoerner M; Dhaussy AC; Prangé T; Kalbitzer HR; Colloc'h N
Chemistry; 2024 Jun; 30(35):e202400304. PubMed ID: 38647362
[TBL] [Abstract][Full Text] [Related]
12. Sugar-based inhibitors of Ras activation: biological activity and identification of Ras-inhibitor binding interface.
Di Domizio A; Peri F
Enzymes; 2013; 33 Pt A():95-116. PubMed ID: 25033802
[TBL] [Abstract][Full Text] [Related]
13. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression.
Al-Mulla F; Milner-White EJ; Going JJ; Birnie GD
J Pathol; 1999 Mar; 187(4):433-8. PubMed ID: 10398103
[TBL] [Abstract][Full Text] [Related]
14. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
Warne PH; Viciana PR; Downward J
Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
[TBL] [Abstract][Full Text] [Related]
15. The allosteric switch and conformational states in Ras GTPase affected by small molecules.
Johnson CW; Mattos C
Enzymes; 2013; 33 Pt A():41-67. PubMed ID: 25033800
[TBL] [Abstract][Full Text] [Related]
16. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
Movilla N; Crespo P; Bustelo XR
Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
[TBL] [Abstract][Full Text] [Related]
18. Amino acid and peptide bioconjugates of copper(II) and zinc(II) complexes with a modified N,N-bis(2-picolyl)amine ligand.
Kirin SI; Dübon P; Weyhermüller T; Bill E; Metzler-Nolte N
Inorg Chem; 2005 Jul; 44(15):5405-15. PubMed ID: 16022539
[TBL] [Abstract][Full Text] [Related]
19. COMBINE analysis of the specificity of binding of Ras proteins to their effectors.
Tomić S; Bertosa B; Wang T; Wade RC
Proteins; 2007 May; 67(2):435-47. PubMed ID: 17295314
[TBL] [Abstract][Full Text] [Related]
20. The effector loop and prenylation site of R-Ras are involved in the regulation of integrin function.
Oertli B; Han J; Marte BM; Sethi T; Downward J; Ginsberg M; Hughes PE
Oncogene; 2000 Oct; 19(43):4961-9. PubMed ID: 11042683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
